0
Letters |

Universal Screening for Methicillin-Resistant Staphylococcus aureus by Hospitals

Rosemary Harris, MD
JAMA. 2008;300(5):503-506. doi:10.1001/jama.300.5.503-a.
Text Size: A A A
Published online

Extract

To the Editor: In their cohort study of universal screening for methicillin-resistant Staphylococcus aureus (MRSA), Dr Harbarth and colleagues1 stated that the intervention was not cost-beneficial from a hospital standpoint. Proposed new rules from the Centers for Medicare & Medicaid Services starting October 1, 2008, would no longer reimburse hospitals or clinicians for certain medical errors, including several categories of hospital-acquired infection.2 I believe that the newfound zeal of US hospitals to screen high-risk patients on admission for MRSA reflects an attempt to mitigate payment reduction or diagnosis-related group reduction for acquired infections by proving that the patient was already infected or at least colonized at the time of admission. These patients can then be isolated and perhaps warrant a higher billing rate based on complexity. Achieving lower infection rates is a laudable goal, but maintaining reimbursement may be the force driving much of this initiative in for-profit hospitals, which could make this intervention cost-beneficial from their perspective.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

August 6, 2008
Cassandra D. Salgado, MD, MS; Margreet C. Vos, MD, PhD; Barry M. Farr, MD, MSc
JAMA. 2008;300(5):503-506. doi:10.1001/jama.300.5.503-b.
August 6, 2008
William R. Jarvis, MD; Carlene Muto, MD, MS
JAMA. 2008;300(5):503-506. doi:10.1001/jama.300.5.504-a.
August 6, 2008
Stephan Harbarth, MD, MS; Didier Pittet, MD, MS
JAMA. 2008;300(5):503-506. doi:10.1001/jama.300.5.504-b.
August 6, 2008
Daniel J. Diekema, MD; Michael Climo, MD
JAMA. 2008;300(5):503-506. doi:10.1001/jama.300.5.505.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();